Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study

INTRODUCTION: The use of immunotherapy in older patients remains challenging due to very few data on the efficacy and safety of treatment in this group. AIM: To analyse the efficacy and safety of immunotherapy with checkpoint inhibitors in older patients (≥ 70 years) with metastatic melanoma. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Cybulska-Stopa, Bożena, Ługowska, Iwona, Jagodzińska-Mucha, Paulina, Koseła-Paterczyk, Hanna, Kozak, Katarzyna, Klimczak, Anna, Świtaj, Tomasz, Ziobro, Marek, Roman, Agnieszka, Rajczykowski, Marcin, Suwiński, Rafał, Niemiec, Maciej, Zemełka, Tomasz, Falkowski, Sławomir, Rutkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906963/
https://www.ncbi.nlm.nih.gov/pubmed/31839773
http://dx.doi.org/10.5114/ada.2018.79940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906963/
https://www.ncbi.nlm.nih.gov/pubmed/31839773
http://dx.doi.org/10.5114/ada.2018.79940

Ejemplares similares